6 ms·
Novo Nordisk facing pressure as study finds $1k drug can be made for $5
- echelon 3y agoOzempic is blowing up on TikTok. Celebs and young people are using it left and right. This is wildly popular and there are resellers and apps popping up everywhere to make it easy to get prescriptions. "Ozempic face" has become a meme as people try to guess who is using it. Several of my neighbors are admittedly using it. And they've lost 30, 40+ pounds in a matter of months. Months. This is a diabetes drug. There has to be a biochemical catch here.
- quotemstr 3y ago> This is a diabetes drug. There has to be a biochemical catch here. What if there isn't a catch? Sometimes technology really does just improve the human condition with no serious downsides. Consider refrigeration or sanitary surgical techniques.
- sandspar 3y agoOzempic's side effects range from frequent diarrhea to pancreatitis and vision loss. Individuals can consider whether the benefits outweigh the costs. But it isn't free. We might try a Fermi problem to estimate how many of those cheerful Ozempic influencers talk about pancreatitis.
- toomuchtodo 3y agoSide effects are real but obesity kills too. Importantly, GLP-1 agonists can also inhibit addictive behaviors (alcohol and substance abuse, gambling) due to a brain chemistry mechanism. Additional harm reduction to consider. https://ourworldindata.org/obesity https://ourworldindata.org/obesity https://www.scientificamerican.com/article/could-new-weight-loss-drugs-like-ozempic-treat-addiction1/ https://www.scientificamerican.com/article/could-new-weight-...
- MichaelZuo 3y agoAll the usable refrigerants were either flammable, toxic, or highly ozone depleting, or a combination, up until the 90s…
- grogenaut 3y agoPretty sure R290 is flammable and I believe being used more and more
- MichaelZuo 3y agoYes, R600 even more so, there are some very expensive exotic refrigerants that are not, but they literally didn’t exist pre 90s.
- koverstreet 3y agoThe human body is a massive system of interconnected feedback loops. Tweak one knob, and there are always cascading side effects. I could entirely see this being a net positive for a lot of people, but I want to know what those side effects are.
- olliej 3y agoPlenty of people have got digestive system paralysis, so that’s a downside. Obviously the big issue is that for people with diabetes this has made the drug unavailable for actual medical problems that don’t have other treatments. Long term studies are also not super complete - even something known to cause cancer like smoking or asbestos takes decades to show up.
- dpacmittal 3y agoRefrigerants contribute to global warming, no?
- QuesnayJr 3y agoI was wondering this. How often does it turn out that a drug has no serious downsides? I guess penicillin was, if you're not allergic. (There is microbes evolving antibiotic resistance, but that's probably not a concern for ozempic.)
- yread 3y agoTry taking strong antibiotics for 2+ weeks. The list of serious downsides will be quite long
- softwreoutthere 3y agoThyroid cancer is one catch.
- pluc 3y agoThey said the same about Viagra.
- Mencius- 3y agoThe Law of Equivalent Exchange can be dodged, delayed, and ignored for only so long. There may not be a biochemical catch, but we will certainly pay in some other way. Perhaps spiritual, mental, etc.
- kobalsky 3y agoimagine if you were saying this about vaccines or antibiotics. this drug has side effects on some people but it’s may make obesity a thing of the past. especially if generics could be made so cheaply
- lxgr 3y agoTo be fair, some people are saying that about vaccines or antibiotics. Fortunately they don’t regulate access to either for most people in the world.
- Mencius- 3y agoDifferent people place different weights on different values and outcomes. I'm sure there are many elderly people who miss the culture of sociability with neighbors that was largely a byproduct of material scarcity. Borrowing the sugar, congregating at the neighbor's house who is the only one on the block with a TV, etc. Our loneliness and mental health crisis is largely the price we paid for vanquishing material scarcity. If you cannot see the dysgenic effects of vaccines, antibiotics, etc I doubt I can convince you in a a single comment. Just take my word for it that the percent of the population that will have permanent defects that require lifelong treatments is continuing to rise. Sperm loads and quality are continuing to drop. I am not implying that these trade-offs aren't worth making -- just that our collective leadership should be making them with eyes wide open and planning for the inevitable sacrifice each piece of 'progress' requires. Edit: Just as a simple thought experiment: If these obesity drugs are really the miracles they seem to be, I can see a future in couple generations where any disruption in supply will lead every single person to balloon to the size of the fattest person you have ever seen in your life. What ever gene(s) are regulating satiation will be rendered moot and thus have zero selection pressure. The outsourcing of this function is just that -- the human organism will no longer have any method of regulating hunger, satiation, etc.
- clan 3y agoWhat I find weirder is that people chase Ozempic even though they have introduced Wegovy. Which is basically the same drug but without glycemic control and hence more suited for non-diabetics. Both are Semaglutides and Wegovy directly targets weight loss.
- ewoodrich 3y agoThey are the exact same active pharmaceutical ingredient (semaglutide), only differ in dosage and the design of the pen used to inject them. Ozempic is a multi use pen while Wegovy comes in fixed dosage single use pens that max out higher than Ozempic's highest dosage. Glycemic control wouldn't be any different between the two at the same dosage but yes, people should really be seeking out Wegovy or Zepbound (tirzepatide) since those actually have a chance of being approved by their insurance for weight loss based on their FDA indication vs Ozempic or Mounjaro.
- SmellTheGlove 3y agoNo it’s the exact same drug. There’s no “without glycemic control” difference. The largest dose of Ozempic available is a little more than the largest Wegovy but it’s the same drug. I’m on Ozempic and not Wegovy. Here’s why: - Wegovy is impossible to get. I had it prescribed a year ago and it still hasn’t been filled. Multiple pharmacies too. - In the meantime, my new insurance doesn’t cover it or Ozempic. So I’m out of pocket. - Ozempic 2mg pens are readily available and unlike Wegovy, you dial the dose, so that 2mg pen lasts me 2 months. It’s not officially indicated and they tell you not to, but just google an Ozempic click chart to see. My doctor was the one who suggested this! - Wegovy pens don’t have variable dosage. Only Ozempic does. - Theres no price difference in the pen sizes for Ozempic or Wegovy near me. No matter what dose pen you get, and no matter if it’s Ozempic or Wegovy, it’s $1000 for a 4 dose equivalent of the prescribed amount. So for me it’s a no brainer if I’m paying retail - give me the highest dose Ozempic pen and I’ll dial the smaller dose that I take. It’ll last me twice as long since I take 1mg weekly. And I can actually get it. The fact that 0.5, 1, and 2mg dose pens all cost the same tells you how badly we’re getting worked here.
- wighty 3y ago> Which is basically the same drug but without glycemic control No... The effects are the same because they are exactly the same drug (semaglutide), the difference is the dosing schedule and max dose (wegovy is 2.4mg and ozempic is 2mg).
- ashconnor 3y agoAds are all over Instagram. Every TRT company is also offering it.
- spanktheuser 3y ago>This is a diabetes drug. It was developed as a drug that increases insulin response, but it also appears to have a substantial impact on CNS processes controlling food cravings and other types of desire. Given that, it’s possible we’ve stumbled upon the mechanism responsible for genetic differences in how we put on weight, whether that’s appetite, metabolic differences or both.
- TeaBrain 3y agoGLP-1 medications have been hypothesized to possibly result in the loss of muscle mass and bone density. There will probably be better data in a few years.
- echelon 3y ago> GLP-1 medications have been hypothesized to possibly result in the loss of muscle mass and bone density. Yikes. I wonder if there could be long term cardiac or pulmonary health issues as a result of this. I'm also interested if this creates long-term insulin or pancreatic dysfunction.
- paulpauper 3y agoOf course, the marginal cost of production is low at scale. Most of the mark-up is for advertising and overhead. Also, once it goes generic that will hurt future sales too.
- lxgr 3y agoNo, it’s for the massive upfront cost of research and regulatory approval. The stuff basically sells itself at this point; marketing probably doesn’t even register in their budget for it.
- paulpauper 3y agothat is what overhead is
- lxgr 3y agoIf you can find a way to cut the overhead of researching new (safe) pharmaceuticals, please do immediately start a company! We could have all kinds of interesting discussions around the parallels between research funding and tech VCs, sprawling regulations and delayed approval procedures etc., but even in a libertarian utopia without an FDA I think you'll find that all researches like getting paid at the end of the month consistently, and not just the few that do eventually hit the jackpot.
- karles 3y agoProducing it is not the hard part. Researching it is... And you are not paid for your research "up front". It's added to the cost afterwards.
- smitty1e 3y ago#DingDingDing In general, mono-dimensional arguments merit an extra dose of skepticism from the audience.
- lxgr 3y agoOn top of research, FDA approval doesn’t come for free either.
- lxgr 3y agoAre the downvotes expression of disapproval with the FDA process or disagreement with the assertion that it's become slow and expensive enough to pose an ethical problem (e.g. for people with diseases for which a cure exists but is still waiting for approval)? Or does anybody actually believe FDA approval is very easy and cheap to come by these days?
- RantyDave 3y agoI'm not Pharma industry expert but ... I'm pretty sure it's much the same as venture capital. That is to say that's it's not that expensive to R&D it, certainly compared to the eventual sale price, but it's carrying the cost of the hundred potential drugs that never made it to market that's the killer.
- max_ 3y agoIt takes $300m to $2B to get a drug approved. And the approval rate is less than 12%. The crazy pricing is to compensate for the failed projects. Also, it's not like you can bootstrap yourself or grow organically like Startups. You have to wait for like 10 - 15 years. To actually start selling it. [1]: https://www.google.com/amp/s/www.policymed.com/amp/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html https://www.google.com/amp/s/www.policymed.com/amp/2014/12/a...
- throwaway5959 3y agoIf the EU can fine Apple and Google, the US should be able to fine Novo.
- lxgr 3y agoIf they have a case against them under US law, sure! Do they?
- Dah00n 3y agoWhy? EU have never gone after Apple or Google because of their prices. This isn't Apple. Novo Nordisk doesn't make medicine that only work if your other medicine is made by them or force you to use their payment card (?!?!?). If your point is the price then the US could go after every single US medicine company.
- throwaway5959 3y agoAbsolutely they should.
- SahAssar 3y agoThat point is a bit different than comparing to Apple and Google.
- throwaway5959 3y agoI didn’t raise it.
- SahAssar 3y ago> If the EU can fine Apple and Google, the US should be able to fine Novo. So what did you mean by that?
- nabla9 3y agoThat's against US law. The US has innovated the laws that make NN profits possible and helped other countries to adopt them. EU created anti trust laws that makes fining Apple and Google possible.
- DarkmSparks 3y agowhy just novo nordisk? https://www.ndtv.com/world-news/at-850-000-drug-to-treat-blindness-could-be-worlds-most-expensive-1795521 https://www.ndtv.com/world-news/at-850-000-drug-to-treat-bli... can be made for .1c heck, a top of the line AMD server chip costing $10,000 only contains a few milligrams of plastic copper gold and sand.
- TylerE 3y ago"There are currently about 1,000 cases of people who suffer from hereditary degeneration of the retina, and 10 to 20 new cases are expected to be added each year." I mean, let's be realistic here.
- DarkmSparks 3y agoso it would be better for orzempic to cost $850,000 and limit its indication to people with MODY? How is that realistic? TBH I have way less a problem with pharma industry being allowed to make profits than health insurance companies. In fact the US is about the only country in the world that allows profits from health insurance.
- Ekaros 3y agoI don't see health insurance making profit being unreasonable. That is key reason why anyone would run an insurance scheme. Now the USA model is entirely wrong. But fundamentally, to offer insurance you must get something out of it.
- DarkmSparks 3y agohealth insurance profit is forgone health. every other country only allows them to exist as not-for-profits. whereas expensive medicines just make health insurance less profitable. This is the basic principle behind why the US spends the most in the world on healthcare to achieve among the worst outcomes (e.g. same life expectancy as most undeveloped 3rd world countries)
- 3y ago
- j7ake 3y agoNovo Nordisk is now Europe’s most valuable company. Congrats to them.
- throwaway35777 3y ago[flagged]
- Scandiravian 3y agoI get that point, but given that Ozempic sells for significantly less in other countries I think it's worth considering why it's that much more expensive in the US
- SmellTheGlove 3y agoExactly this. And it’s because the US consumer is paying for the R&D on drugs for the rest of the world. We could balance this out a bit by passing a law that says the retail cost of a drug in the US can’t be any higher than the median of the EU + Canada (or something approximating the set of developed economies).
- Scandiravian 3y agoI do get that point, but I'm not sure it would actually work Drug prices in the US are, in part, higher because FDA requirements are much, much stricter so it's more difficult to actually get a drug approved. It's simply more expensive to launch a product in the US, so if it becomes less profitable it might not be worth the risk for companies You could also risk that drug companies launch an analogue of the effective compound in the US to circumvent such a regulation, since it would be two different drugs The reason it's cheaper in Europe is in some part due to having single payer healthcare, which mean that there's a single entity negotiating purchase prices for the entire country, which improves bargaining power significantly
- xyzal 3y agoIsn't everything healthcare-related much more expensive in the US?
- Unfrozen0688 3y ago[flagged]
- dang 3y agoYou've been breaking the site guidelines so frequently with this account that I think we have to ban it. Can you please not create accounts to break HN's rules with? We're trying for something a bit different here than internet default, and would appreciate your help. https://news.ycombinator.com/newsguidelines.html https://news.ycombinator.com/newsguidelines.html
- eliben 3y agoAdobe facing pressure as study finds $99 program can be made for $0
- andrewstuart 3y agoI literally laughed out loud when I read this and that actually pretty much never happens despite sending LOL in text messages.
- lxgr 3y agoLet’s be reasonable here: CDNs aren’t free. They might be spending a couple of cents per user! But yeah, people might not like the implementation or idea of intellectual property, but that’s what’s happening here. Pretending it’s something else makes it hard to argue about it.
- hackernewds 3y agoyou're missing the point I think. if the first pill wear charged a billion dollars, the ones after could go for $5 each. same argument for Adobe.
- musicale 3y ago$60/month, but that does include 100 GB of storage that you might otherwise have to store on a $20 SD card.
- kgbcia 3y agoGoes for any software that can be copied
- lostlogin 3y agoIt’s not quite the same, although I’m assuming that no one needs Adobe to stay alive.
- hackernewds 3y agohow is it any different
- Scandiravian 3y agoI think the complexity of the issue isn't really reflected by the article. The most obvious points that are missing are the risks associated with developing a new drug, the costs of research, and the regulatory requirements from the FDA Since pharmaceutical companies are, for the most part, publicly traded they're beholden to stock holders to create a profit. If they stop doing that they're in trouble If the ability to generate profit from developing new drugs are limited, they'll simply stop doing it Personally I think this kind of profit incentive for healthcare is perverse and ultimately doesn't serve public interest, but until the systemic issues behind these prices are addressed, I find it difficult to see a solution that'll ultimately benefit the end-user
- lostlogin 3y agoRegulating drug pricing is what has started to happen. And I’ll bet they don’t like that. A single payer system would at least change the negotiating power that big pharma has - even in a small market, drug companies hate dealing with a single buying. Here in New Zealand the point even made it into the TPP agreement negotiations. The US wanting our (deeply imperfect) healthcare system to be a bit more like the US one is rather grim.
- Scandiravian 3y agoCompletely agree. That's part of why Ozempic is cheaper in Europe. I actually worked for the company who negotiates drug purchases for all hospitals here in Denmark (Amgros), so I'm somewhat familiar with the process There's flaws in this approach as well, but in the end it's definitely an improvement to the issues US patients are facing in regards to costs
- aceofspades19 3y agoNo, publicly traded companies are beholden to act in the interests of the shareholders which in practicality is fairly vague. All companies are sort of designed to turn a profit or try to as they generally need that to continue existing but there is no legal requirement that they need to create a profit or maximize it, publicly traded or not. Obviously, companies do try to maximize profit as it makes everyone involved money but they don't have to.
- quotemstr 3y agoThe world no longer has an obesity problem. It has a semaglutide access problem. We can't manufacture virtue at scale, but we can make vast amounts of a simple organic compound. Give it away. The public health benefits will pay for themselves.
- kwhitefoot 3y agoWouldn't be better for people to simply eat better? Obesity levels are much lower in Norway than they are in the UK and US. As far as I can tell this is because in Norway we simply eat less fast and ultraprocessed food.
- quotemstr 3y ago> Wouldn't be better for people to simply eat better? Has a half-century of telling people to "simply eat better" worked?
- kwhitefoot 3y agoI didn't say anything about telling people to eat better. Perhaps what might work would be to make good healthy food more available and affordable and the rubbish less affordable and less available.
- hilux 3y agoBy the same logic, all software should be free, because the cost of manufacturing the bits is zero! (Yes, I'm very aware of rms and the FSF.)
- kaashif 3y ago> (Yes, I'm very aware of rms and the FSF.) rms and the FSF believe selling software is totally fine as long as you provide source code to your users. They don't think there's any moral imperative for software to be free as in priced at $0, but software should respect its users' freedom.
- icegreentea2 3y agoThe paper models a competitive (cheaper) and conservative (more expensive) pricing. The conservative model assumes a 50% profit for Ozempic (the competitive model assumes 10%). These are margins that cannot realistically sustain drug development in the current western regulatory regime. At the same time, its quite clear that the cost of drugs, particularly in the US is out of control. In that sense, focusing on the fact that a company that received the technical data package and plant for manufacturing Ozempic for free could then indefinitely sell Ozempic for $5 a month is a red herring, and not likely to lead to any fruitful change. The price differential between US pricing and say... UK pricing ($350 a month for injectable Ozempic vs ~$80 a month) is enough to hammer in on. On a side note, what I found interesting is that while the article says a injectable Ozempic can cost ~1k a year, the actual study marks it at more like $350 a month.
- homero 3y agoYeah that's almost every drug so what
- 8thcross 3y agothis is the conundrum the US Pharma is facing. GLP1 took NN 10+ years of investment to come up. Acquired podcast has a great story about them. The middleman is what is different between the various country healthcare systems. USDOJ is trying/tried going after but one word - lobby. The regulation required is for consumer to directly buy from pharma skipping all middlemen. my 2cents.
- sudosysgen 3y agoNN didn't come up with GLP1. It's a natural peptide, and people have been taking it for a very long time. Nordisk did get it approved, yes, and that was costly, but let's not massively overstate the innovation. Semaglutide is not GLP1, it's a bit different. But it's not the first GLP1 analog. It's not even the first to be approved : AstraZeneca was the first to get a GLP1 agonist approved, in 2005. In fact, it even is used off label for obesity. Nordisk's big break was convincing the regulators to get it approved for obesity and not just type 2 diabetes.
- tokai 3y agoAll drug research and production should just be done with public money by the public sector. Drug companies are already deeply reliant on university produced researchers and research, and in most cases the actual drug production is trivial. Imagine the human and economic benefits if there was no profit barrier to health.
- Quinzel 3y agoDoesn’t the price of a drug come down only once the patent expires and other drug companies can start making it? But the reason they have patents that last like 20 years is to allow them to recover the costs of R&D.
- lvl102 3y agoWho educates these scientists through PhD programs? Oh, OK. So we are paying these people to get their PhDs so they can go and start a company to scalp people with drugs that deliver 10% lift in efficacy. What a scam model.
- Cupprum 3y agoHow much do you know about this? Novo Nordisk sponsors many universities around Denmark, they pay a lot of money for those graduates.
- deleted 3y ago[deleted]
- Ekaros 3y agoI'm not sure there is other model, unless we move to entirely funding drug research publicly. And then set some bidding process for manufacturing...
- andrewstuart 3y agoSo this boils down simply to cost based pricing versus value based pricing. Novo Nordisk is applying a pricing strategy that reflects demand and what people are willing to pay. https://en.wikipedia.org/wiki/Value-based_pricing https://en.wikipedia.org/wiki/Value-based_pricing There are many, many MANY people in this world will to pay for this on the basis of value. Heck if I had a lazy $5,000 I'd buy 5 months worth of the stuff and I'd be extremely happy with my purchase and I would not care what it cost to make. Losing 20 kilos is easily worth $5K to me. The only problem is I can't get it at any price - Wegovy is simply not available here in Australia and for all I know it might take 10 years until they can make enough to supply the market. If someone could get it for me I would pay them except I'd never trust the black market - you're unlikely to be getting the real thing.
- nabla9 3y agoThere is currently a supply problem. Novo Nordisk is building more capacity, but it takes time. Meantime those who are willing to pay more for it, get it. Mostly citizens of rich countries. Novo Nordisk is controlled by the Novo Nordisk Foundation (> 77.1% of votes, 28.1% of capital) with aim to make a positive impact on health, science, and society by generating long-term returns on the assets of the Novo Nordisk Foundation. One of the reasons why Novo Nordisk has been so successful is because their owner takes a long term view in R&D unlike purely profit-seeking owner.
- fvdessen 3y agoI find it a bit jarring that first reaction from the American public to foreign companies finding success in the USA is think about nationalising them. You see this in this thread, but also with TikTok. It's especially strange given the usual total economic dominance of the USA over the rest of the world. Did big tech get so rich by charging low prices ? Is the rest of the world 'subsidising' the Silicon Valley ?
- deleted 3y ago[deleted]
- j7ake 3y agoThey made a product that people want to pay lots of money for. I don’t see why they should not be allowed to price this product to meet the insanely high demand. How much it costs to make is irrelevant to the discussion. This drug wouldn’t have existed without Novo Nordisk, they deserve to profit so they can continue making new drugs. What is next, should we limit the amount of money JK Rowling can make off her books because it is essentially free to produce?
- gizajob 3y agoYou know what else is cheap and helps with weight loss? Bicycles.
- RcouF1uZ4gsC 3y agoI want Pharma to be incredibly profitable. I want kids to sign up for chemistry majors hoping they can work for pharmacy companies rather than sign up for computer science hoping they can work for companies serving ads. I want there to be full employment for experts in drug design and testing. I don’t want Pharma to be a limited profitability industry that slowly loses money and talent to other industries such as tech or entertainment. I want kids to dream of becoming the next billionaire by develops drug that cures cancer rather than becoming a billionaire by inventing a more addictive social media app. Talent goes where the money is. If the money gets removed, the innovation will slowly go away. And like with Boeing, it may take decades for the results to be fully realized. Covid-19 demonstrated how important Pharma was to society. With the vaccines, Pharma yielded a consumer surplus of literally trillions of dollars (just from being able to re-open the economies). Yes there was academia that had the basic research, but you needed companies and scientists that had years and years of experience designing, testing, productionizing, and distributing medicines and vaccines.
- datavirtue 3y agoWait until everyone realizes the drug does more harm than good.
- sschueller 3y ago[flagged]
- aaomidi 3y agoNot understanding how this medication makes this possible is part of the problem here.
- D-Coder 3y agoYeah, that's been working so well for forty years.
- pfdietz 3y agoYes, the eat and exercise thing has never been tried. Why didn't anyone think of this first? Next up, the "just don't do bad things" approach to improving society. It's genius!
- sschueller 3y agoStop making excuses, a large part of the world does not have an obesity epidemic. Ozempic has it's uses but only a very small percentage of the population actuality need it. Same goes for the masses of men over 30 that think they need testosterone replacement therapy. Unless you abused steroids or you have an underlying issues that prevents your gonads from working you do not need it. In fact a major factor in low testosterone is excessive body weight.
- RealityVoid 3y agoI strongly success people listen to the Aquired episode on Novo Nordisk. It's quite interesting and we'll researched. https://www.acquired.fm/episodes/novo-nordisk-ozempic https://www.acquired.fm/episodes/novo-nordisk-ozempic If you don't want to listen, there is the transcript right there on the page. In there, they mentioned "It's pretty interesting. Pharma as a whole of the medical pie only occupies about 13% of revenue." ”The administrative costs of health insurance are 8%." "I will say, who is taking any risk in this whole ecosystem? It's only pharma. Who's taking risk to innovate and make anything better? Every other bet that a hospital makes or that an insurance company is just probably going to pay off." Say what you will, but pharma is pushing healthcare forward so I am not against them making money. Of course, I also don't want people to have lack of healthcare access because merely money, so there is a line to tow here. The way insurance and drug pricing works in the US is bonkers and I would not solely blame pharma for that.
- sizzle 3y agoBiosimilars couldn’t come soon enough. These companies are profiting off these billion dollar blockbuster drugs, even the R&D scientists are getting peanuts for creating the novel molecules, yet the biopharma company blocks everyone from reproducing drugs under the broken patent system. Biosimilars benefit us all by reducing prices like generics do. Someone correct me if I’m wrong
- 1letterunixname 3y ago"I object to this obvious communism attacking defenseless megacorporations. Also, cheap insulin is killing us." - what Martin Shkreli would say
- SebFender 3y agoOver simplifying but the real questions are - How long did it take to create - How long did it take to streamline manufacturing - What were the associated costs and so on. Then what's the real cost distribution over current practices. I'm sure the answer isn't a 1000$ and certainly not 5$ - but maybe something in between or a bit less? Articles like these are too simple and lack perspective for clicks...